APA (7th ed.) Citation

Lepper, A. (2024). The study on myeloid-derived suppressor cells (MDSCs) and T cells in melanoma patients with adverse events after immunotherapy immune checkpoint inhibitors.

Chicago Style (17th ed.) Citation

Lepper, Alisa. The Study on Myeloid-derived Suppressor Cells (MDSCs) and T Cells in Melanoma Patients with Adverse Events After Immunotherapy Immune Checkpoint Inhibitors. Heidelberg, 2024.

MLA (9th ed.) Citation

Lepper, Alisa. The Study on Myeloid-derived Suppressor Cells (MDSCs) and T Cells in Melanoma Patients with Adverse Events After Immunotherapy Immune Checkpoint Inhibitors. 2024.